Xiao-lei Bao

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

Yiming Mu, Xiao-lei Bao, Freddy G. Eliaschewitz et al. · The Lancet Diabetes & Endocrinology · 2024 · 114 citations

Medicine, Pharmacology, Pharmacotherapy +8

Characterization of a Novel G3P[3] Rotavirus Isolated from a Lesser Horseshoe Bat: a Distant Relative of Feline/Canine Rotaviruses

Biao He, Fanli Yang, Weihong Yang et al. · Journal of Virology · 2013 · 81 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China

Ning Cui, Xiao-lei Bao, Zhen‐Dong Yang et al. · Journal of Clinical Virology · 2013 · 67 citations

Medicine, Hematology, Internal Medicine +5

Group A Rotaviruses in Chinese Bats: Genetic Composition, Serology, and Evidence for Bat-to-Human Transmission and Reassortment

Biao He, Xiaohong Huang, Fuqiang Zhang et al. · Journal of Virology · 2017 · 44 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial

Soo Lim, Supawan Buranapin, Xiao-lei Bao et al. · The Lancet Diabetes & Endocrinology · 2025 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +9